|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO-B
Nominal 
3.190 -0.010 (-0.313%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 225,352 | 1347.162% | 15,572 | 0 | 0 | 0 |
| Cost of Sales | (28,277) | 1310.324% | (2,005) | -- | -- | -- |
| Gross Profit | 197,075 | 1352.606% | 13,567 | -- | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 174,976 | -- | (62,816) | (76,285) | (77,991) | (38,312) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (27,341) | -15.172% | (32,231) | (17,695) | (12,084) | (8,675) | |
| Profit / (Loss) before Taxation | (30,301) | -95.668% | (699,441) | (1,028,869) | (613,448) | (515,492) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 8,205 | -21.022% | 10,389 | 17,873 | 31,599 | 68,456 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (22,096) | -96.793% | (689,052) | (1,010,996) | (581,849) | (447,036) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,756 | -- | (37,272) | 1,538 | 81,013 | 52,162 |
| Depreciation & Amortisation | 102,572 | 7.466% | 95,446 | 95,246 | 84,114 | 49,266 |
| Directors' Emoluments | 15,291 | -18.786% | 18,828 | 25,525 | 5,226 | 0 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -1.000 | -97.619% | -42.000 | -66.000 | -51.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.151) | -- | (0.293) | (0.409) | (0.372) | -- |
| NBV per share ($) | 0.540 | -- | 0.543 | -- | -- | -- |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -192,430,000 |
| %Change | 35.606% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 0.535 |